The success of NIPRO’s biosimilar product, launched in late 2023, has exceeded expectations and gained significant market ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug ...

Will significantly enhance service to researchers and institutions across China.

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.

AdvanCell, a clinical-stage radiopharmaceutical company specializing in targeted alpha therapies, is expanding the scope and ...

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to CUSP06, a Cadherin-6 targeting ...

Telix Pharmaceuticals Ltd.’s prostate cancer PET imaging agent Illuccix has been approved by the Danish Medicines Agency.

Alcami Corporation, a contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry ...

Novartis has agreed to acquire Anthos Therapeutics, Inc., a Boston-based, privately held, clinical-stage biopharmaceutical ...

PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...

Bain Capital, a global private investment firm, has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma ...